Skip to main content

103 publications

Name Date Type Actions

2008 activity report

25/05/2009 Annual Report

2008 Annual earnings

Operating highlights
- Key figures
- Revenues
- External growth
- A strategy of product innovation

01/04/2009 Annual Report

2008 annual earnings

The Vétoquinol Board of Directors, meeting on March 20, 2009, reviewed the group’s business and approved the group’s 2008 financial statements.

31/03/2009 Public releases

2008 financial report

Laboratoire pharmaceutique vétérinaire familial et indépendant, Vétoquinol se consacre exclusivement à la santé animale. Son activité est volontairement équilibrée entre animaux de rente et animaux de compagnie.
<br>
Historiquement implanté sur le marché français, le groupe réalise désormais 78% de son chiffre d'affaires consolidé à l'international (234,4 millions d'euros en 2008). Les 1400 collaborateurs du Groupe se répartissent entre la Recherche & Développement, la production et la commercilisation.
<br>
Aujourd'hui, la PME française -11e acteur mondial en santé animale (hors aliments)- produit et distribue 700 médicaments et produits non médicamenteux dans près de 100 pays (Europe, Amérique du Nord et Asie). Elle s'appuie sur ses filiales dans 22 pays et sur un réseau de 140 partenaires distributeurs.

04/05/2009 Reference document

2008 revenue: €234.4 M

Revenue grew in 2008, despite poor economic conditions in the second half and
an unfavourable comparison effect

22/01/2009 Public releases

2009 Revenue improvement in trends in the first quarter

Vétoquinol’s revenue for the first quarter of 2009 reached €57.1 M, an increase of 4.4% over the first quarter of 2008.

09/04/2009 Public releases

2010 calendar of financial communication

December 7, 2009 (Lure, France) – Vétoquinol published its calendar of financial
communication for 2010.

07/12/2009 Agenda

2015 Annual Results

2015 Annual Results

22/03/2016 Annual Report

2015 Registration document

Note to recipient of this document: this is the translation of an extract of the Registration Document and Annual Financial Report for the year ended December 31, 2015. The original French document was filed with the AMF (French Financial Markets Authority) on April 26, 2016.

27/04/2016 Reference document

2015 results sales of reference products up 9.4% ebit up 10.3%

At its meeting on March 18, 2016, the Vetoquinol S.A. Board of Directors reviewed the Group’s results and approved the 2015 financial statements.

21/03/2016 Public releases